Comparison of the performance of two real-time fluorescent quantitative PCR kits for the detection of SARS-CoV-2 nucleic acid: a study based on large real clinical samples
Open Access
- 18 November 2022
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 19 (1) , 1-10
Abstract
Background: The global pandemic of coronavirus disease 2019 (COVID-19) has led to the development of multiple detection kits by national manufacturers for severe acute respiratory syndrome coronavirus 2 viral nucleic acid testing. The purpose of this study is to evaluate the performance of different kits (i.e., Maccura kit and Sansure kit) in real clinical work using clinical samples, which will help with the optimization of the test kits. Method: During the past three months (March–May 2022), 1399 pharyngeal swabs from suspected COVID-19 patients have been initially screened using the Maccura kit in Jilin, China, and the test results were verified using the Sansure kit. The cycle threshold (Ct) values generated by the two kits were compared at different viral load levels. Correlation and consistency of the Ct values were investigated using Spearman correlation, Deming regression, and Bland–Altman plots. The cut-off Ct values of the Maccura kit were recalculated by referencing the result of the Sansure kit as a standard. Furthermore, another 163 pharyngeal swabs from suspected COVID-19 patients were collected to verify the new cut-off values. Results: As a result of the Maccura kit testing, 1192 positive cases and 207 suspected COVID-19 cases were verified. After re-examination by the Sansure kit, 1118 positive cases were confirmed. The difference between the Ct values provided by the two kits was statistically significant, except for the N gene at high viral load. The Ct values obtained from the two kits presented a linear positive correlation. The Maccura kit used new cut-off Ct values of 35.00 (ORF1ab gene) and 35.07 (N gene). Based on that, the validation pass rate for the new cut-off Ct values was 91.41%. Conclusion: Since the Maccura kit is found to have false positives in actual clinical work, recalculation of the cut-off values can reduce this occurrence. In order to improve the accuracy of the testing, laboratories should use two kits for COVID-19 testing, and the adjusting and optimizing of the kits for their situation are needed.Keywords
Funding Information
- Jiancheng Xu (20190304110YY)
- Qi Zhou (20200404171YY)
This publication has 29 references indexed in Scilit:
- Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19Virologica Sinica, 2020
- Evaluation of seven commercial RT‐PCR kits for COVID‐19 testing in pooled clinical specimensJournal of Medical Virology, 2020
- Comparison of the diagnostic efficacy between two PCR test kits for SARS‐CoV‐2 nucleic acid detectionJournal of Clinical Laboratory Analysis, 2020
- Nucleic Acid Testing for Coronavirus Disease 2019: Demand, Research Progression, and PerspectiveCritical Reviews in Analytical Chemistry, 2020
- Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since ExposureAnnals of Internal Medicine, 2020
- COVID-19 outbreak: Migration, effects on society, global environment and preventionScience of The Total Environment, 2020
- Pitfalls in SARS‐CoV‐2 PCR diagnosticsTransboundary and Emerging Diseases, 2020
- False‐positive reverse transcriptase polymerase chain reaction screening for SARS‐CoV‐2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implicationsHead & Neck, 2020
- Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2Theranostics, 2020
- Laboratory diagnosis of emerging human coronavirus infections – the state of the artEmerging Microbes & Infections, 2020